Literature DB >> 22009686

Concise review: Oct4 and more: the reprogramming expressway.

Jared Sterneckert1, Susanne Höing, Hans R Schöler.   

Abstract

Through cellular differentiation, a single cell eventually gives rise to all the various lineages of an organism. This process has traditionally been viewed as irreversible. However, nuclear transfer experiments have demonstrated that differentiated cells can be reprogrammed to form even an entire organism. Yamanaka electrified the world with the discovery that expression of only four transcription factors was sufficient to induce pluripotency in differentiated somatic cells of mammals. Expansion of this work has shown that expression of the master pluripotency gene Oct4 is sufficient to induce pluripotency in neural stem cells. In contrast to somatic cells, germline cells express Oct4 and can acquire pluripotency without the addition of exogenous transcription factors. More recently, it has been possible to also induce an alternative cell fate directly by the transdifferentiation of cells mediated by the introduction of specific transcription factors, including Oct4. Therefore, we suggest that Oct4 is the gatekeeper into a reprogramming expressway that can be directed by altering the experimental conditions.
Copyright © 2011 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22009686     DOI: 10.1002/stem.765

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  38 in total

Review 1.  Generation of pluripotent stem cells without the use of genetic material.

Authors:  Akon Higuchi; Qing-Dong Ling; S Suresh Kumar; Murugan A Munusamy; Abdullah A Alarfaj; Yung Chang; Shih-Hsuan Kao; Ke-Chen Lin; Han-Chow Wang; Akihiro Umezawa
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

Review 2.  Erase and Rewind: Epigenetic Conversion of Cell Fate.

Authors:  Georgia Pennarossa; Alessandro Zenobi; Cecilia E Gandolfi; Elena F M Manzoni; Fulvio Gandolfi; Tiziana A L Brevini
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

3.  The Pou5f1 distal enhancer is sufficient to drive Pou5f1 promoter-EGFP expression in embryonic stem cells.

Authors:  Ji Liao; Yikun He; Piroska E Szabó
Journal:  Int J Dev Biol       Date:  2013       Impact factor: 2.203

4.  End of inevitability: programming and reprogramming.

Authors:  Kursad Turksen
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

5.  Sumoylation is important for stability, subcellular localization, and transcriptional activity of SALL4, an essential stem cell transcription factor.

Authors:  Feikun Yang; Yixin Yao; Yongping Jiang; Luo Lu; Yupo Ma; Wei Dai
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

6.  The pioneer factor OCT4 requires the chromatin remodeller BRG1 to support gene regulatory element function in mouse embryonic stem cells.

Authors:  Hamish W King; Robert J Klose
Journal:  Elife       Date:  2017-03-13       Impact factor: 8.140

7.  The involvement of mitochondrial fission in maintenance of the stemness of bone marrow mesenchymal stem cells.

Authors:  Xiaorong Feng; Wenjing Zhang; Wen Yin; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-06

8.  Mixl1 localizes to putative axial stem cell reservoirs and their posterior descendants in the mouse embryo.

Authors:  Adam D Wolfe; Karen M Downs
Journal:  Gene Expr Patterns       Date:  2014-03-12       Impact factor: 1.224

Review 9.  Application of iPS cells in dental bioengineering and beyond.

Authors:  Pengfei Liu; Yanmei Zhang; Shubin Chen; Jinglei Cai; Duanqing Pei
Journal:  Stem Cell Rev Rep       Date:  2014-10       Impact factor: 5.739

10.  Generation of embryonic stem cell lines from immature rabbit ovarian follicles.

Authors:  Takeshi Teramura; Hironobu Sugimoto; John Frampton; Yuta Kida; Miho Nakano; Makiko Kawakami; Hiroki Izumi; Naoto Fukunaga; Yuta Onodera; Toshiyuki Takehara; Kanji Fukuda; Yoshihiko Hosoi
Journal:  Stem Cells Dev       Date:  2012-11-21       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.